While early, the results indicate drugs known as ITK inhibitors have the potential to match or surpass the efficacy observed ...
Long-term data suggest Moderna’s personalized melanoma shot provides “durable tumor control,” one analyst said. Elsewhere, ...
Amid patent expirations, litigation and tariff costs, J&J says it expects more growth ahead, fueled in part by its blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback